-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Opinion|Videos|January 6, 2025

Key Background Information on Recurrent C. Difficile Infections

Panelist discusses how recurrent Clostridioides difficile infection results from persistent microbiome disruption, where antibiotic-induced dysbiosis enables bacterial overgrowth and toxin production. Characterized by repeated episodes of colitis, it predominantly affects older, hospitalized patients with compromised immune systems, presenting significant clinical challenges through inflammatory complications and potential systemic spread.

Video content above is prompted by the following:

  • Describe the pathophysiology of recurrent C difficile infection and what the potential complications of recurrent C difficile include.
  • What is the role of the microbiome?
  • Discuss the epidemiology and the risk factors for developing recurrent C difficile infection.

Related to this article

Andrew D. Zelenetz, MD, PhD, is the chair of the NCCN B-cell Lymphomas panel.  | Image: LinkedIn
The National Comprehensive Cancer Network update on mantle cell lymphoma puts covalent BTK inhibitors, MRD testing, and TP53 sequencing at the center of frontline care, while adding pirtobrutinib and a pair of CAR T-cell therapies for disease that progresses on a BTK inhibitor.